RAB39B: A novel biomarker for acute myeloid leukemia identified via multi-omics and functional validation
In conclusion, RAB39B shows potential as a biomarker for the identification and prediction of AML, contributing to the growth and cell death processes in AML.
Authors
- Mengxing Li (ORCID: https://orcid.org/0000-0003-3989-2993)
- Jishi Wang (ORCID: https://orcid.org/0009-0007-1053-6588)
- Shuo Chen (ORCID: https://orcid.org/0000-0002-7990-4947)
Institutions
- Guiyang Medical University (CN)
- Affiliated Hospital of Guizhou Medical University (CN)
Publication Details
- Journal
- Open Medicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1515/med-2025-1168
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00